Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc. (NYSE: A) is a global company in analytical and clinical laboratory technologies, and its news flow reflects activity across life sciences, diagnostics, and applied markets. Company announcements highlight how Agilent’s instruments, software, services, and expertise are used to help customers bring great science to life, as well as how it manages its financial performance and corporate governance.
On this page, readers can follow Agilent news related to earnings results, product introductions, regulatory-focused solutions, capital allocation, and investor events. Recent releases include quarterly and full-year financial results, with details on revenue, net income, and segment performance for the Life Sciences and Diagnostics Markets Group, the Agilent CrossLab Group, and the Applied Markets Group. These updates often include management commentary on business conditions and outlook.
Agilent’s news also covers product and technology developments. For example, the company has announced 21 CFR Part 11 compliance software for the xCELLigence RTCA eSight system, designed to support use in GMP-regulated manufacturing and quality control environments by adding secure user authentication, electronic signatures, and audit trails. Another announcement introduced Agilent Altura Ultra Inert HPLC Columns, described as high performance liquid chromatography columns suited for biotherapeutics applications such as peptide GLP-1 and oligonucleotide therapeutic development and quality control.
Investors and analysts can also find updates on capital markets activities, such as cash dividend declarations on Agilent’s common stock, and notices of participation in healthcare and investor conferences. Governance-related news, including leadership transitions and executive appointments, is communicated through press releases and related SEC filings. Bookmarking this page allows users to review Agilent’s ongoing communications about its operations, technologies, financial performance, and corporate developments in one place.
Summary not available.
Summary not available.
Summary not available.
Agilent Technologies Inc. (NYSE: A) has partnered with METTLER TOLEDO to enhance laboratory efficiency and accuracy in sample preparation. Their integrated solution automates the transfer of weighing results from METTLER TOLEDO's LabX Balance software to Agilent's OpenLab software, thus minimizing errors and improving workflows. This innovation aims to eliminate common transcription errors and accelerate digital transformation in labs. The collaboration was announced at Analytica 2022 in Munich and emphasizes the commitment to improving lab productivity.
Agilent Technologies reported strong Q3 2022 results, with revenue of $1.72 billion, reflecting an 8% year-over-year increase. GAAP net income reached $329 million or $1.10 EPS, a 28% increase from last year. Non-GAAP net income was $401 million with $1.34 EPS, up 22%. The company has raised its full-year revenue guidance to $6.750-$6.775 billion, indicating 6.8%-7.2% growth. Expected Q4 revenue is $1.750-$1.775 billion with non-GAAP EPS of $1.38-$1.40.
Agilent Technologies Inc. (NYSE: A) has acquired Polymer Standards Service GmbH (PSS) to enhance its offerings in polymer characterization. PSS specializes in gel permeation chromatography (GPC) and size exclusion chromatography (SEC), crucial for analyzing macromolecules. This acquisition aims to expand Agilent's product portfolio, particularly in chemical and biopharmaceutical industries. The integration will leverage Agilent’s global reach to broaden the use of PSS's technologies and products. Financial terms of the acquisition have not been disclosed.
Agilent Technologies (NYSE: A) has awarded the Agilent Thought Leader Award to Professor Gerhardt Attard from University College London for his groundbreaking research in prostate cancer using innovative liquid biopsy technologies. The award will support the identification of biomarkers related to cancer progression through analysis of circulating tumor DNA. Professor Attard expressed excitement about the potential of his research to enhance diagnostic tools for cancer treatment. Agilent's commitment to funding such research highlights its ongoing investment in advancing cancer genomics and diagnostics.
Agilent Technologies (NYSE: A) announced that Stefanos Nikolaidis, an Assistant Professor at USC Viterbi School of Engineering, received the 2022 Early Career Professor Award for his contributions to AI and Machine Vision in manufacturing. This award emphasizes Agilent's commitment to innovative technology in manufacturing, particularly in developing intuitive collaborative robots (cobots). Dr. Nikolaidis' research aims to enhance manufacturing capabilities and ensure timely delivery of high-quality scientific instruments. The company generated $6.32 billion in revenue in fiscal 2021.
Summary not available.
Agilent Technologies (NYSE: A) has been recognized with a Top Project award for its Certified Pre-Owned Instruments Program, which reduces waste significantly. The program allows lab customers to trade in used instruments for cash or new purchases, promoting sustainability. In fiscal 2021, Agilent bought back over 900 used instruments and sold more than 3,500 certified pre-owned instruments. The initiative aligns with Agilent's commitment to net-zero emissions by 2050 and enhances their Environmental, Social and Governance (ESG) efforts.